Factors associated with overall survival, progression-free survival and toxicity in patients with small cell lung cancer and thoracic irradiation in a clinical real-world setting

被引：0
|
作者：
Marie-Theres Kassik
Dirk Vordermark
Christine Kornhuber
Daniel Medenwald
机构：
[1] University Hospital Halle/Saale,Department of Radiation Therapy
来源：
Radiation Oncology | / 18卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Prophylactic Cranial Irradiation-Related Lymphopenia Affects Progression-Free Survival in Patients With Small Cell Lung Cancer
    Fan, X.
    Li, B.
    Wang, S.
    Fan, B.
    Wang, C.
    Yang, L.
    Qin, W.
    Zhang, D.
    Wang, L.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 111 (03): : E465 - E466
  • [22] Predicting Real-World Effectiveness of Cancer Therapies Using Overall Survival and Progression-Free Survival from Clinical Trials: Empirical Evidence for the ASCO Value Framework
    Lakdawalla, Darius N.
    Shafrin, Jason
    Hou, Ningqi
    Peneva, Desi
    Vine, Seanna
    Park, Jinhee
    Zhang, Jie
    Brookmeyer, Ron
    Figlin, Robert A.
    VALUE IN HEALTH, 2017, 20 (07) : 866 - 875
  • [23] Increasing progression-free survival in non-small cell lung cancer
    不详
    BRITISH JOURNAL OF HOSPITAL MEDICINE, 2009, 70 (09) : 498 - 498
  • [24] Overall and progression-free survival of patients with metastatic colorectal cancer: A real-world prospective, longitudinal cohort study on the continuum of care (PROMETCO)
    Koopman, M.
    Garcia-Carbonero, R.
    Pinto, C.
    Mitroshkin, A.
    Bodoky, G.
    Mineur, L.
    Bourgeois, V.
    Mare, M.
    Ruiz-Casado, A.
    Fernandez Montes, A.
    O'Connor, J. M. R.
    Sullivan, A.
    Choucair, E.
    Sicaire, M.
    Marti, F. E.
    Bachet, J-B.
    ANNALS OF ONCOLOGY, 2023, 34 : S434 - S435
  • [25] Progression-free survival as surrogate endpoint of overall survival in esophageal squamous cell carcinoma: a real-world data and literature-based analysis
    Han, Weiming
    Wang, Lan
    Li, Chen
    Chen, Junqiang
    Zhang, Wencheng
    Wang, Xin
    Pang, Qingsong
    Zhao, Yidian
    Sun, Xinchen
    Zhang, Kaixian
    Li, Gaofeng
    Li, Ling
    Qiao, Xueying
    Liu, Miaoling
    Wang, Yadi
    Deng, Lei
    Wang, Wenqing
    Bi, Nan
    Zhang, Tao
    Deng, Wei
    Ni, Wenjie
    Chang, Xiao
    Zhou, Zongmei
    Liang, Jun
    Feng, Qinfu
    Wang, Lvhua
    Chen, Dongfu
    Lv, Jima
    Zhu, Shuchai
    Han, Chun
    Xiao, Zefen
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2022, 14
  • [26] Adding Erlotinib to Chemoradiation Improves Overall Survival but Not Progression-Free Survival in Stage III Non-Small Cell Lung Cancer
    Komaki, Ritsuko
    Allen, Pamela K.
    Wei, Xiong
    Blumenschein, George R.
    Tang, Ximing
    Lee, J. Jack
    Welsh, James W.
    Wistuba, Ignacio I.
    Liu, Diane D.
    Hong, Waun Ki
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 92 (02): : 317 - 324
  • [27] Real-World Progression-Free Survival as an Endpoint in Lung Cancer: Replicating Atezolizumab and Docetaxel Arms of the OAK Trial Using Real-World Data
    Mhatre, Shivani K.
    Machado, Robson J. M.
    Ton, Thanh G. N.
    Trinh, Huong
    Mazieres, Julien
    Rittmeyer, Achim
    Bretscher, Michael T.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2023, 114 (06) : 1313 - 1322
  • [28] Predictors of Response, Progression-Free Survival, and Overall Survival in Patients With Lung Cancer Treated With Immune Checkpoint Inhibitors
    Memmott, Regan M.
    Wolfe, Adam R.
    Carbone, David P.
    Williams, Terence M.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (07) : 1086 - 1098
  • [29] Progression-free survival as a surrogate endpoint of overall survival in patients with metastatic colorectal cancer
    Cicero, Giuseppe
    De Luca, Rossella
    Dieli, Francesco
    ONCOTARGETS AND THERAPY, 2018, 11 : 3059 - 3063
  • [30] Predictive factors for poor progression-free survival in patients with non-small-cell lung cancer treated with nivolumab
    Taniguchi, Y.
    Tamiya, A.
    Isa, S-I.
    Nakahama, K.
    Okishio, K.
    Shiroyama, T.
    Suzuki, H.
    Inoue, T.
    Tamiya, M.
    Nishino, K.
    Kumagai, T.
    Hirashima, T.
    Imamura, F.
    Atagi, S.
    ANNALS OF ONCOLOGY, 2017, 28
12345